These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 36202899)

  • 1. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
    Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
    Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
    Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
    J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.
    Lin Z; Zou J; Sui X; Yao S; Lin L; Wang J; Zhao J
    Sci Rep; 2022 Sep; 12(1):16285. PubMed ID: 36175606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
    Xie Y; Xu Z; Mei X; Shi W
    Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis.
    Zhao J; Zou J; Jiao W; Lin L; Wang J; Lin Z
    Sci Rep; 2022 Nov; 12(1):18813. PubMed ID: 36335189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
    Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
    Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
    [No Abstract]   [Full Text] [Related]  

  • 10. Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance.
    Ma J; Jin Y; Gong B; Li L; Zhao Q
    Discov Oncol; 2022 Mar; 13(1):17. PubMed ID: 35312867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
    Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
    Front Immunol; 2022; 13():968165. PubMed ID: 36389725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
    Chen D; Guo W; Yu H; Yang J
    Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
    Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D
    BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
    Wang L; Qu H; Ma X; Liu X
    Oxid Med Cell Longev; 2022; 2022():1056825. PubMed ID: 36225179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Eight-Gene Signature for Lipid Metabolism Predicts the Progression of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Wang S; Zhang S
    Reprod Sci; 2024 Feb; 31(2):514-531. PubMed ID: 37749448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma.
    Hu D; Zhang Z; Zhang Y; Huang K; Li X
    Front Genet; 2023; 14():1137995. PubMed ID: 37007965
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
    Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
    Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
    Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients.
    Zhu Z; Lu J
    Medicine (Baltimore); 2024 May; 103(19):e38116. PubMed ID: 38728474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.